Genmab A/S (GMAB)
NASDAQ·Healthcare·Biotechnology
$29.05
+1.27%
Mkt Cap $16.79B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (21 analysts)
$38.30
Range $32.00 – $41.50
Implied Upside
+31.9%
Consensus $38.30 vs current $29.05
NASDAQ·Healthcare·Biotechnology
$29.05
+1.27%
Mkt Cap $16.79B
Buy
3
Hold
0
Sell
0
Price Target (21 analysts)
$38.30
Range $32.00 – $41.50
+31.9%
Consensus $38.30 vs current $29.05